Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Chemistry & Biology
|
November 13, 2012
Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity
Hao Li, Elizabeth L Ponder, Martijn Verdoes, et al.
Plos Neglected Tropical Diseases
|
June 27, 2015
Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
Sean Ekins, Jair Lage de Siqueira-Neto, Laura-Isobel McCall, et al.
Chemistry & Biology
|
June 25, 2011
Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors
Elizabeth L Ponder, Victoria E Albrow, Brittany A Leader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Marisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Chemistry & Biology
|
November 13, 2012
Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity
Hao Li, Elizabeth L Ponder, Martijn Verdoes, et al.
Plos Neglected Tropical Diseases
|
June 27, 2015
Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
Sean Ekins, Jair Lage de Siqueira-Neto, Laura-Isobel McCall, et al.
Chemistry & Biology
|
June 25, 2011
Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors
Elizabeth L Ponder, Victoria E Albrow, Brittany A Leader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Marisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Page
of 2